StonvexLoading…
StonvexStonvexStonvexCore line items from NTRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.30B | $1.34B | $5.02B | $3.71B | $2.44B |
Operating Income | Not available | $700.60M | $2.34B | $1.71B | $1.09B |
Net Income | Not available | $525.50M | $1.74B | $1.27B | $421.30M |
EPS (Diluted) | $2.69 | $2.71 | $8.74 | $6.32 | $4.03 |
Total Assets | Not available | $174.57B | $177.13B | $170.26B | $171.88B |
Total Liabilities | Not available | $161.59B | $164.17B | $157.31B | $159.02B |
Cash & Equivalents | Not available | $5.82B | $5.87B | $5.35B | $6.42B |
Free Cash Flow OCF − CapEx | Not available | $-329.40M | $5.46B | $5.10B | $4.59B |
Shares Outstanding | Not available | 185.05M | 186.34M | 189.12M | 191.23M |